Clinical trial
Post Hoc Analysis and Clinical Data Collection for Subjects Tested With Brain Network Activation (BNA™) Technology
NCT03699514 is registered in ClinicalTrials.gov with ElMindA Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Hoc Analysis and Clinical Data Collection for Subjects Tested With Brain Network Activation (BNA™) Technology
- Lead sponsor
- ElMindA Ltd
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 1, 2018
- Completion date
- January 1, 2023
- Enrollment
- 10,000 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
cognitive impairment, healthy, neurological disorder